The cytosolic 5’-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells

Abstract : The cytosolic 5'-nucleotidase cN-II is a highly conserved enzyme implicated in nucleotide metabolism. Based on recent observations suggesting additional roles not directly associated to its enzymatic activity, we studied human cancer cell models with basal or decreased cN-II expression. We developed cancer cells with stable inhibition of cN-II expression by transfection of shRNA-coding plasmids, and studied their biology. We show that human breast cancer cells MDA-MB-231 with decreased cN-II expression better adapt to the disappearance of glucose in growth medium under normoxic conditions than cells with a baseline expression level. This is associated with enhanced in vivo growth and a lower content of ROS in cells cultivated in absence of glucose due to more efficient mechanisms of elimination of ROS. Conversely, cells with low cN-II expression are more sensitive to glucose deprivation in hypoxic conditions. Overall, our results show that cN-II regulates the cellular response to glucose deprivation through a mechanism related to ROS metabolism and defence.
Liste complète des métadonnées

Littérature citée [35 références]  Voir  Masquer  Télécharger

https://hal.archives-ouvertes.fr/hal-01611275
Contributeur : Laure-Estelle Cassagnes <>
Soumis le : jeudi 5 octobre 2017 - 15:55:14
Dernière modification le : jeudi 8 février 2018 - 11:09:56
Document(s) archivé(s) le : lundi 8 janvier 2018 - 14:43:10

Fichier

18653-271864-3-PB.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Citation

Gabriel Bricard, Octavia Cadassou, Laure-Estelle Cassagnes, Emeline Cros-Perrial, Léa Payen-Gay, et al.. The cytosolic 5’-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells. Oncotarget, Impact journals, 2017, 〈10.18632/oncotarget.18653〉. 〈hal-01611275〉

Partager

Métriques

Consultations de la notice

241

Téléchargements de fichiers

39